HA15 T6855
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
HA15 targets specifically BiP/GRP78/HSPA5. HA15 exhibits anti-cancerous activity on all melanoma cells tested, including cells isolated from patients and cells that developed resistance to BRAF inhibitors.
CAS nr:
1609402-14-3
Purity:
98%
Molecular Weight:
466,58
SMILES:
CC(=O)Nc1nc(c2cccc(NS(=O)(=O)c3c4cccc(N(C)C)c4ccc3)c2)cs1
Formula:
C23H22N4O3S2
Pathway:
Metabolism,Cytoskeletal Signaling,Endocrinology/Hormones,GPCR/G Protein,Others,Autophagy,Apoptosis
Target:
HSP,HSP,GPR,GPR,Others,Autophagy,Apoptosis
